Efficacy-to-tolerability ratio is lower for female rats on GLP1R agonists As a first step to investigate biological mechanisms underlying sex differences in the response to GLP1R agonists, we administered a single dose of semaglutide or tirzepatide in male and female Wistar rats across a wide range of doses (0.0003 mg/kg up to 0.3 mg/kg
[2] Chohan MO, Bragina O, Kazim SF, Statom G, Baazaoui N, Bragin D, Iqbal K, Nemoto E, Yonas H
Interventional Pain Management: Everything You Need to Know What Does a Pain Management Physician Do
Strategies for Managing Post-Discontinuation Effects Knowing that a relatively large proportion of patients are likely to stop their GLP-1 RA use for whatever reason, its important to plan an exit strategy for them before they start treatment
$99/mo, cancel anytime
Gastroparesis is one of the most common concerns we hear about, and the good news is that it rarely requires stopping treatment